Evidence map›Paper›PMID 31324746›Full record

ArticleG3 (Bethesda, Md.)2019

Richard K Babbs, Jacob A Beierle, Qiu T Ruan, Julia C Kelliher, Melanie M Chen, Ashley X Feng, Stacey L Kirkpatrick, Fabiola A Benitez, Fred A Rodriguez, Johanne J Pierre and 4 more

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Richard K BabbsLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.
Jacob A BeierleLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.
Qiu T RuanLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.
Julia C KelliherLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.
Melanie M ChenLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.
Ashley X FengLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.
Stacey L KirkpatrickLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.
Fabiola A BenitezLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.
Fred A RodriguezLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.
Johanne J PierreLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.
Jeya AnandakumarLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry.
Vivek KumarThe Jackson Laboratory, 600 Main St., Bar Harbor, ME 04609, and.
Megan K MulliganDepartment of Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, 71 S. Manassas St, Memphis, TN 38163.
Camron D BryantLaboratory of Addiction Genetics, Department of Pharmacology and Experimental Therapeutics and Psychiatry camron@bu.edu.ORCID 0000-0003-4505-5809
Boston University · USJackson Laboratory · USUniversity of Tennessee Health Science Center · US

Funding

TRAINING IN BIOMOLECULAR PHARMACOLOGYT32GM008541 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI FARB, DAVID H · 1997 to 2022
$5.2M
Bridging genetic variation with behavior: Molecular and functional mechanisms of quantitative trait gene regulation of the stimulant and addictive properties of methamphetamine in miceR01DA039168 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BRYANT, CAMRON D · 2015 to 2019
$3.0M
Sequencing Mutant Mice With Altered Cocaine ResponsesU01DA041668 · NIDA · JACKSON LABORATORY · PI KUMAR, VIVEK · 2016 to 2020
$2.8M
Genetic basis of binge eating and its motivational components in a reduced complexity crossR21DA038738 · NIDA · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BRYANT, CAMRON D · 2015 to 2016
$463k
QUANTSTUDIO 12K FLEX OPEN ARRAY REAL-TIME PCR SYSTEMS10OD023663 · OD · BOSTON MEDICAL CENTER · PI DENG, LINGYI L · 2017 to 2017
$186k
NIDA NIH HHS R01 DA039168NIDA NIH HHS R21 DA038738NIDA NIH HHS U01 DA041668NIGMS NIH HHS T32 GM008541NIH HHS S10 OD023663Wellcome Trust
6 · The paper itself

Abstract

Binge eating (BE) is a heritable trait associated with eating disorders and involves episodes of rapid, large amounts of food consumption. We previously identified cytoplasmic FMR1-interacting protein 2 (

Indexed as

HaploinsufficiencyAdaptor Proteins, Signal TransducingAnimalsAntigens, NeoplasmAppetite RegulationBehavior, AnimalCompulsive BehaviorFemaleFragile X Messenger Ribonucleoprotein 1HypothalamusIntracellular Signaling Peptides and ProteinsIntrinsically Disordered ProteinsMaleMice, Inbred C57BLMice, KnockoutProteinsAdaptor Proteins, Signal TransducingAntigens, NeoplasmCyfip1 protein, mouseCyfip2 protein, mouseFmr1 protein, mouseFragile X Messenger Ribonucleoprotein 1Intracellular Signaling Peptides and ProteinsIntrinsically Disordered ProteinsMagel2 protein, mouseProteinsaddiction geneticsanorexia nervosabinge eating disorderC57BL/6 substrainsFMRPFragile XGenetics of Sexneuropsychiatricovereatingpsychiatric genetics

Identifiers

PMID31324746
PMCPMC6723122
OpenAlexW2962857843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.